Search Results
., Doebele, R. C., et al.: A phase II, open-label study of ramucirumab in combination with paclitaxel and carboplatin as first-line therapy in patients with stage IIIB/IV non-small-cell lung cancer
-reactive protein in the patients with stage I lung cancer. Zhongguo Fei Ai Za Zhi, 2011, 14 (5), 400–403. [Article in Chinese] 16 Shen, L., Li, Z. M., Lu, S.: Clinical
.: Extracellular matrix proteins protect small cell lung cancer cell against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo . Nat Med 5 , 662-668 (1999). Extracellular matrix proteins protect small
100 101 Omenn, G. S., Goodman, G. E., Thornquist, M. D. et al.: Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol
Morano, M. T., Araújo, A. S., Nascimento, F. B., et al.: Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group: The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancer in male smokers. N. Engl. J. Med., 1994, 330 , 1029–1035. The
References [1] Khuder , S. A. 2001 Effect of cigarette smoking on major histological types of lung cancer: a meta analysis Lung Cancer 31 139 – 148 . [2] Burns , D. M. 2003 Epidemiology of smoking-induced cardiovascular
microRNAs as novel biomarkers for early detection of lung cancer. Int. J. Clin. Exp. Pathol., 2011, 4 , 575–586. Wang Y. Plasma microRNAs as novel biomarkers for early detection of lung
HORIUCHI, N., NAKAGAWA, K., SASAKI, Y., MINATO, K., FUJIWARA, Y., NEZU, K., OHE, Y. & SAIJO, N. (1988): In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by
241 248 Griffey, S. M., Kraegel, S. A. and Madwell, B. R. (1999): Proliferation indices in spontaneous ca-nine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB
